North Star Investment Management’s Moderna MRNA Stock Holding History

North Star Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05K	Hold	15	–	–	﹤0.01%	1534
2026 Q1	$762	Hold	15	–	–	﹤0.01%	1531
2025 Q4	$442	Buy	+15	New	+$408	﹤0.01%	1529
2023 Q4	–	Sell	-6	Closed	-$620	–	1258
2023 Q3	$620	Hold	6	–	–	﹤0.01%	1185
2023 Q2	$729	Hold	6	–	–	﹤0.01%	1191
2023 Q1	$921	Hold	6	–	–	﹤0.01%	1175
2022 Q4	$1.08K	Buy	+6	New	+$981	﹤0.01%	1150
2022 Q3	–	Sell	-50	Closed	-$7K	–	1163
2022 Q2	$7K	Sell	50 -75	-60%	-$10.7K	﹤0.01%	888
2022 Q1	$22K	Hold	125	–	–	﹤0.01%	728
2021 Q4	$32K	Hold	125	–	–	﹤0.01%	702
2021 Q3	$48K	Hold	125	–	–	﹤0.01%	594
2021 Q2	$29K	Hold	125	–	–	﹤0.01%	684
2021 Q1	$16K	Sell	125 -50	-29%	-$7.25K	﹤0.01%	721
2020 Q4	$18K	Hold	175	–	–	﹤0.01%	689
2020 Q3	$12K	Sell	175 -35	-17%	-$2.44K	﹤0.01%	725
2020 Q2	$13K	Hold	210	–	–	﹤0.01%	687
2020 Q1	$6K	Buy	+210	New	+$4.83K	﹤0.01%	795

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

North Star Investment Management's MRNA Position: Q2 2026 in Review

North Star Investment Management held its Moderna (MRNA) position steady in Q2 2026 at 15 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1534.

North Star Investment Management first reported a position in MRNA in Q1 2020 and has held it in 17 quarters since. The position peaked at $48K in Q3 2021. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

North Star Investment Management held 15 shares of Moderna worth $1.05K as of Q2 2026.
North Star Investment Management left its Moderna share count unchanged in Q2 2026.
Moderna made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #1534 holding.
North Star Investment Management first reported a position in Moderna in Q1 2020 and has held it in 17 quarters since.
North Star Investment Management's Moderna position peaked at $48K in Q3 2021.
784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.